The Patent Finder

Terms ending in 2028

Intervet Inc.

Every in-force patent on Intervet Inc.'s record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,980,283C. perfringens alpha toxoid vaccine
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 7,732,187Recombinant Attenuated Clostridium Organisms and Vaccine
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 9,593,303Method for Continuously Culturing Ehrlichia and Neorickettsia Risticii
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 12,324,657System And Method for Diagnosis Of Bovine Diseases Using Auscultation Analysis
In force
 · High confidence
Intervet Inc.In forceHigh confidence
US 8,791,242Canine Thymic Stromal Lymphopoietin Protein and Uses Thereof to Treat Allergic Symptoms
In force
 · High confidence
Intervet Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited